Postoperative weight gain may be related to invasive tumor treatment, which damages the paraventricular nucleus and the suprachiasmatic nucleus, leads to loss of satiety, and inhibits the interaction of leptin, insulin, and intestinal hormones (35, 36). Here, INS is linked to neoplasm.